Jeffrey A. Munsie
Conseiller Juridique Général chez CONCERT PHARMACEUTICALS, INC.
Profil
Jeffrey A.
Munsie is currently the Chief Legal Officer at Concert Pharmaceuticals, Inc. Prior to his current position, he served as the SVP, Head-Operations & General Counsel at Merrimack Pharmaceuticals, Inc. from 2017 to 2019.
Before that, he worked as Counsel at Wilmer Cutler Pickering Hale & Dorr LLP from 2002 to 2011.
Mr. Munsie completed his undergraduate studies at Dartmouth College and obtained his graduate degree from Harvard Law School.
Postes actifs de Jeffrey A. Munsie
| Sociétés | Poste | Début |
|---|---|---|
| CONCERT PHARMACEUTICALS, INC. | Conseiller Juridique Général | 23/09/2019 |
Anciens postes connus de Jeffrey A. Munsie
| Sociétés | Poste | Fin |
|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Directeur des opérations | 01/07/2019 |
Wilmer Cutler Pickering Hale & Dorr LLP
 Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Wilmer Cutler Pickering Hale & Dorr LLP provides legal services. It specializes in trial, appellate, securities, regulatory, intellectual property, corporate transactions, bankruptcy, environmental, labor and employment, private client, real estate and tax matters. The company was founded in 1918 and is headquartered in Boston, MA. | Conseiller Juridique Général | 01/01/2011 |
Formation de Jeffrey A. Munsie
| Harvard Law School | Graduate Degree |
| Dartmouth College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Wilmer Cutler Pickering Hale & Dorr LLP
Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Wilmer Cutler Pickering Hale & Dorr LLP provides legal services. It specializes in trial, appellate, securities, regulatory, intellectual property, corporate transactions, bankruptcy, environmental, labor and employment, private client, real estate and tax matters. The company was founded in 1918 and is headquartered in Boston, MA. | Commercial Services |
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA. | Health Technology |
